Earlier this month, I traveled to Montenegro for a gathering of longevity enthusiasts, people interested in extending human lifespan through various biotechnological approaches. All participants were very friendly and the atmosphere was optimistic. They are all convinced they can find a way to slow or reverse aging and have bold plans to accelerate the aging process.
About 780 of these have set up “pop-up cities” aimed at circumventing the traditional clinical trial process. They want to create an independent nation where like-minded innovators can work together in entirely new jurisdictions where they can freely self-test unproven drugs. Welcome to Zuzal. Please read the full text.
China is not waiting to make rules on generative AI
Back in April, China’s internet regulator released draft regulations on generative AI. While the document doesn’t name any specific companies, it’s clear from the way it’s worded that it’s inspired by the constant deployment of large language model chatbots in China and the United States.
The draft regulation combines sensible limits on AI risks with the continuation of the Chinese government’s strong tradition of proactive intervention in the tech industry. But while many of the draft regulation’s provisions are principles advocated by AI critics in the West, they also contain rules that other countries are likely to hesitate to adopt. Please read the full text.
— Yang Zei